BioServices in Medical Technology
The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine
... United States with an H5N1 reverse genetic reassorted (RG)
Indonesia strain vaccine. Baxter is also working with the NIAID in
partnership with Fisher bioservices
Inc. on a Phase I trial in the United
States using the H5N1 Vietnam strain.
About Pandemic Flu
A pandemic is a global disease outbreak of a virus ...
Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
working with the U.S. National Institute of Allergy and Infectious
Diseases, part of the National Institutes of Health, in partnership with
Inc., and with the U.S. Department of Health and Human
Services, in partnership with DVC LLC, a Computer Science Corporation
Company, to further devel...
Baxter Announces Final Phase I/II Data and Initiation of Phase III
Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
...lso working with the U.S. National Institute of
Allergy and Infectious Diseases, part of the National Institutes of
Health, in partnership with Fisher bioservices
Inc., and with the
U.S. Department of Health and Human Services, in partnership with
DVC LLC, a Computer Science Corporation Company, to further devel...
BioServices in Biological News
Could fungal collection hold the key to new life-saving drugs?
... Scientists may be one step closer to finding new drugs to fight MRSA, cancers and other diseases, after CABI, a leading bioservices
organisation announced that its fungal collection will be screened by the University of Strathclyde.
CABI houses one of the world’s largest genetic ...
BioServices in Biological Technology
Avid Bioservices Presents Data From Manufacturing Successes Achieved With Single-Use Bioreactor Systems
TUSTIN and SAN DIEGO, Calif., Feb. 13 /PRNewswire-FirstCall/ -- Avid
Bioservices, Inc. today reported that it presented data from several antibody
projects using the company's recently installed Single-Use Bioreactors
(S.U.B.) at the Thermo Scientific BioProduction Optimization Workshop held
Avid Bioservices Expands Capabilities With Installation of Innovative Thermo Scientific HyClone Single-Use Bioreactor Systems
TUSTIN, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Avid Bioservices,
Inc. today announced that it is expanding its biomanufacturing capabilities
with the installation of two Thermo Scientific HyClone Single-Use
Bioreactors (S.U.B.) in Avid's facility in Tustin, California. These
ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
- Pre-IND meeting with FDA scheduled for January for lead antibody program -
TORONTO, Dec. 5 /PRNewswire-FirstCall/ - ARIUS Research Inc. (TSX:
ARI), a biotechnology company discovering and developing the next wave of
antibody therapeutics, today announced that...
Paragon Bioservices, Inc. Wins 2009 Lilly Global Supplier Award
...of Paragon Bioservices.
Nominated by Lilly's Elanco affiliate, Paragon bioservices
was one of fifteen companies selected from among 6500 Lilly global suppliers.
About Paragon Bioservices, Inc.
( www.paragonbioservices.com ) offers contract services for accelerating ...
Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009
efficacy trial and in the Phase I dosing and dosimetry trial in patients
with GBM, the deadliest form of brain cancer.
-- Avid bioservices
became the first U.S. pre-approved contract
manufacturer for licensees of the DSM Biologics and Crucell PER.C6(R) cell
line, a proprietary high yield ...
Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
...nti-VEGF agents may have potential advantages over non-selective approaches.
Avid Bioservices: -- Wholly owned manufacturing subsidiary Avid bioservices
signed an agreement with ARIUS Research to produce clinical supplies of their lead cancer stem cell anti-CD44 antibody. -- Avid continued ...
ARIUS announces fourth quarter and year-end fiscal 2007 financial results
... potent tumor growth inhibitory activity in in vivo animal models of breast, prostate, liver, and AML cancers. - Engaged the manufacturer Avid bioservices
to produce ARIUS' lead anti-CD44 MAb under Current Good Manufacturing Practices ("cGMP") for human clinical trials. Cell line producing the ...
Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
...nt efforts through Sangamo's leadership position in zinc finger protein technology. The acquisitions of Epichem and Molecular Medicine bioservices
during the first half of 2007 also supported our goal of growth from acquisitions by adding $52 million in annualized revenues in other desi...
BioServices in Biological Products
Immunohistochemistry - Gene Discovery from Paragon BioServices
Description: This service involves the optimization of immunostaining. The optimization includes titration of the primary antibody, selection and optimization of secondary reagents (e.g. Alk. Phos., HRP, fluorescence, or biotinylated conjugates), optimization of detection, evaluation by light or fluorescence m...